Mono Pharmacare Stock Price Analysis and Quick Research Report. Is Mono Pharmacare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Mono Pharmacare. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Mono Pharmacare has a PE ratio of 13.7221269296741 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Mono Pharmacare has ROA of 5.5472% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Mono Pharmacare has a Current ratio of 2.5865.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Mono Pharmacare has a ROE of 10.4208%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Mono Pharmacare has a Debt to Equity ratio of 0.7594 which means that the company has low proportion of debt in its capital.

• Sales growth: Mono Pharmacare has reported revenue growth of 16.8565% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Mono Pharmacare for the current financial year is 3.10222069486258%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Mono Pharmacare is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Mono Pharmacare is Rs 1.749. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Mono Pharmacare in Ticker for free. Also, one can get the intrinsic value of Mono Pharmacare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Mono Pharmacare FAQs

Q1. What is Mono Pharmacare share price today?
Ans: The current share price of Mono Pharmacare is Rs 24.

Q2. What is the market capitalisation of Mono Pharmacare?
Ans: Mono Pharmacare has a market capitalisation of Rs 42.4045536 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Mono Pharmacare?
Ans: The PE ratio of Mono Pharmacare is 13.7221269296741 and the P/B ratio of Mono Pharmacare is 1.35915732246007, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Mono Pharmacare share?
Ans: The 52-week high share price of Mono Pharmacare is Rs 38, and the 52-week low share price of Mono Pharmacare is Rs 20.65.

Q5. Does Mono Pharmacare pay dividends?
Ans: Currently, Mono Pharmacare does not pay dividends. Dividend yield of Mono Pharmacare is around 0%.

Q6. What are the face value and book value of Mono Pharmacare shares?
Ans: The face value of Mono Pharmacare shares is Rs 10, while the book value per share of Mono Pharmacare is around Rs 17.658. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Mono Pharmacare?
Ans: Mono Pharmacare has a total debt of Rs 23.6928 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Mono Pharmacare?
Ans: The ROE of Mono Pharmacare is 10.4208% and ROCE of Mono Pharmacare is 10.4202%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Mono Pharmacare a good buy for the long term?
Ans: The Mono Pharmacare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Mono Pharmacare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Mono Pharmacare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Mono Pharmacare’s financials?
Ans: You can review Mono Pharmacare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.